Verdict in the case of therapies versus eosinophils: the jury is still out.
about
Anti-Siglec-F antibody reduces allergen-induced eosinophilic inflammation and airway remodelingA review of eosinophilic gastroenteritisInterleukin-5 priming of human eosinophils alters siglec-8 mediated apoptosis pathwaysNovel Therapies for Eosinophilic DisordersRe-defining the unique roles for eosinophils in allergic respiratory inflammationOccurrence of apoptosis, secondary necrosis, and cytolysis in eosinophilic nasal polyps.Anti-IL5 decreases the number of eosinophils but not the severity of dermatitis in Sharpin-deficient miceWhat targeting eosinophils has taught us about their role in diseases.Polymorphisms in the sialic acid-binding immunoglobulin-like lectin-8 (Siglec-8) gene are associated with susceptibility to asthma.Eosinophilic pneumonias.Anti-interleukin-5 antibody therapy in eosinophilic diseases.Strain-specific requirement for eosinophils in the recruitment of T cells to the lung during the development of allergic asthma.Novel targeted therapies for eosinophilic disordersSiglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors.Paired immunoglobulin-like receptor A is an intrinsic, self-limiting suppressor of IL-5-induced eosinophil development.CCR3 antagonists: a survey of the patent literature.An update on anti-allergic patents granted in China: 2009 - 2011.Plasminogen activator inhibitor-2 (PAI-2) in eosinophilic leukocytes.
P2860
Q24645925-6FAFDDBD-D3C1-486B-9AB7-0CE5F9A8754FQ24651045-6FA1655C-F107-4898-81A8-539A249C01E7Q24685595-D9D557F1-7691-4215-8F6C-93FBCBDAEFADQ26799600-A799E79A-7B06-4BD3-BD18-E466C63C5C28Q26828515-51882D1F-BDD9-4934-A16D-786FAD4ABB0DQ33204402-0E89CEEE-967D-4F97-A529-20B980CC5A76Q33780705-765D8E0A-1323-49F8-A087-D0A85B19D2DFQ33987218-597C363F-E235-497E-9BFE-73CB9B4D6EFCQ34329191-1C1ACAAC-122E-416D-8846-01086FCE20B6Q36149065-6CD56DFC-AF47-450E-A086-998E74751D67Q36438486-4765C55B-DF3E-43AC-9E98-8158686CE848Q36699742-B6A2E9F0-ACDF-4C42-8417-B0DBD80060FFQ36763565-31A79839-9AB0-4CB2-8016-E392B84531FBQ37343465-B0FED596-4807-4C0E-A439-BD78BF7507F6Q37407592-71FFBA4D-C482-44F4-B79A-931E6D7FB1B4Q37564516-8F77F366-917B-4EFE-ADE3-EA284091C0D6Q38019004-A24C0D5A-2A03-4F8D-A544-7CBE785CC74FQ47950786-5FD69F07-32B7-4DB6-987F-A5DDA5E448B2
P2860
Verdict in the case of therapies versus eosinophils: the jury is still out.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Verdict in the case of therapies versus eosinophils: the jury is still out.
@ast
Verdict in the case of therapies versus eosinophils: the jury is still out.
@en
type
label
Verdict in the case of therapies versus eosinophils: the jury is still out.
@ast
Verdict in the case of therapies versus eosinophils: the jury is still out.
@en
prefLabel
Verdict in the case of therapies versus eosinophils: the jury is still out.
@ast
Verdict in the case of therapies versus eosinophils: the jury is still out.
@en
P1476
Verdict in the case of therapies versus eosinophils: the jury is still out.
@en
P2093
Bruce S Bochner
P304
3-9; quiz 10
P356
10.1016/J.JACI.2003.09.046
P407
P577
2004-01-01T00:00:00Z